Individual physician practice variation in hematopoietic cell transplantation

Journal of Clinical Oncology

Volumn 26, Issue 13, 2008, Pages 2162-2170

  Lee, Stephanie J ^a   Joffe, Steven ^b   Artz, Andrew S ^b   Champlin, Richard E ^b   Davies, Stella M ^b   Jagasia, Madan ^b   Kernan, Nancy A ^b   Loberiza Jr , Fausto R ^b   Soiffer, Robert J ^b   Eapen, Mary ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL PRACTICE; CONDITIONING; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTERNET; MALE; MEDICAL DECISION MAKING; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; AGED; ALLOTRANSPLANTATION; BLAST CELL CRISIS; DECISION MAKING; DEMOGRAPHY; EPIDEMIOLOGY; GRAFT VERSUS HOST REACTION; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHATIC LEUKEMIA; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATIENT SELECTION; PRACTICE GUIDELINE; QUESTIONNAIRE; STANDARD; STATISTICS;

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; DECISION MAKING; FEMALE; GRAFT VS HOST DISEASE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERNET; LEUKEMIA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUALITY OF HEALTH CARE; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 43749091065     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.0169     Document Type: Article

References (37)

1. Wennberg J, Gittelsohn A: Small area variations in health care delivery. Science 182:1102-1108, 1973
2. Grytten J, Sorensen R: Practice variation and physician-specific effects. J Health Econ 22:403-418, 2003
3. Kravitz RL, Greenfield S: Variations in resource utilization among medical specialties and systems of care. Annu Rev Public Health 16:431-445, 1995
4. Silberman G, Crosse MG, Peterson EA, et al: Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med 331:1063-1067, 1994
5. Gratwohl A, Brand R, Apperley J, et al: Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: Transplant activity, long-term data and current results: An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 91:513-521, 2006
6. Gratwohl A, Baldomero H, Schwendener A, et al: Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe-impact of cost considerations. Leukemia 21:383-386, 2007
7. Gratwohl A, Baldomero H, Frauendorfer K, et al: Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: Focus on increasing use of unrelated donors. Bone Marrow Transplant 39:71-87, 2007
8. Windrum P, Morris TC, Drake MB, et al: Variation in dimethyl sulfoxide use in stem cell transplantation: A survey of EBMT centres. Bone Marrow Transplant 36:601-603, 2005
9. Ruutu T, Niederwieser D, Gratwohl A, et al: A survey of the prophylaxis and treatment of acute GVHD in Europe: A report of the European Group for Blood and Marrow, Transplantation (EBMT): Chronic Leukaemia Working Party of the EBMT. Bone Marrow Transplant 19:759-764, 1997
10. Hsu B, May R, Carrum G, et al: Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: An international practice survey. Bone Marrow Transplant 28:945-950, 2001
11. Trifilio S, Verma A, Mehta J: Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: Heterogeneity of current clinical practice. Bone Marrow Transplant 33:735-739, 2004
12. Lee SJ, Vogelsang G, Gilman A, et al: A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant 8:32-39, 2002
13. Ruutu T, Hermans J, van Biezen A, et al: How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party: European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 22:614-615, 1998
14. Parsons SK, Hoorntje LE, Levine KJ, et al: Balancing efficacy with cost: Antiemetic control in the pediatric stem cell transplant (SCT) population. Bone Marrow Transplant 25:553-557, 2000
15. Lafata JE, Simpkins J, Schultz L, et al: Routine surveillance care after cancer treatment with curative intent. Med Care 43:592-599, 2005
16. Lindenauer PK, Pekow P, Gao S, et al: Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 144:894-903, 2006
17. Choy H, Shyr Y, Cmelak AJ, et al: Patterns of practice survey for nonsmall cell lung carcinoma in the U.S. Cancer 88:1336-1346, 2000
18. Ng AK, Li S, Neuberg D, et al: Factors influencing treatment recommendations in early-stage Hodgkin's disease: A survey of physicians. Ann Oncol 15:261-269, 2004
19. Taghian A, Jagsi R, Makris A, et al: Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys 60:706-714, 2004
20. Katz SJ, Lantz PM, Janz NK, et al: Surgeon perspectives about local therapy for breast carcinoma. Cancer 104:1854-1861, 2005
21. United Nations World Macro regions and components 2007. http://www.un.org/depts/dhl/maplib/worldregions/htm
22. Schrezenmeier H, Passweg JR, Marsh JC, et al: Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110:1397-1400, 2007
23. Champlin RE, Perez WS, Passweg JR, et al: Bone marrow transplantation for severe aplastic anemia: A randomized controlled study of conditioning regimens. Blood 109:4582-4585, 2007
24. Bruno B, Rotta M, Patriarca F, et al: A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356:1110-1120, 2007
25. Creutzig U, Reinhardt D: Current controversies: Which patients with acute myeloid leukaemia should receive a bone marrow transplantation? A European view. Br J Haematol 118:365-377, 2002
26. Chen AR, Alonzo TA, Woods WG, et al: Current controversies: Which patients with acute myeloid leukaemia should receive a bone marrow transplantation? An American view. Br J Haematol 118:378-384, 2002
27. Hasle H, Arico M, Basso G, et al: Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7: European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 13:376-385, 1999
28. Woods WG, Barnard DR, Alonzo TA, et al: Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: A report from the Children's Cancer Group. J Clin Oncol 20:434-440, 2002
29. Van Lint MT, Uderzo C, Locasciulli A, et al: Early treatment of acute graft-versus-host disease with high- or low- dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 92:2288-2293, 1998
30. Asch DA, Jedrziewski MK, Christakis NA: Response rates to mail surveys published in medical journals. J Clin Epidemiol 50:1129-1136, 1997
31. Wusthoff CJ, McMillan A, Ablin AR: Differences in pediatric oncologists' estimates of curability and treatment recommendations for patients with advanced cancer. Pediatr Blood Cancer 44:174-181, 2005
32. Charles CA, Yee VS, Dusza SW, et al: Variation in the diagnosis, treatment, and management of melanoma in situ: A survey of US dermatologists. Arch Dermatol 141:723-729, 2005
33. Peabody JW, Luck J, Glassman P, et al: Comparison of vignettes, standardized patients, and chart abstraction: A prospective validation study of 3 methods for measuring quality. JAMA 283:1715-1722, 2000
34. Veloski J, Tai S, Evans AS, et al: Clinical vignette-based surveys: A tool for assessing physician practice variation. Am J Med Qual 20:151-157, 2005
35. Eagle KA, Goodman SG, Avezum A, et al: Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359:373-377, 2002
36. Hawley ST, Hofer TP, Janz NK, et al: Correlates of between-surgeon variation in breast cancer treatments. Med Care 44:609-616, 2006
37. Alexander KP, Newby LK, Bhapkar MV, et al: International variation in invasive care of the elderly with acute coronary syndromes. Eur Heart J 27:1558-1564, 2006